By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > Three Clinical Insights from Landmark Lung Cancer Surgery Study

Three Clinical Insights from Landmark Lung Cancer Surgery Study

GMJ
Last updated: 14/07/2026 03:17
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
Medical illustration showing lung surgery outcomes comparison between smoking and non-smoking patients
New research from University of Cincinnati shows lung cancer patients who continue smoking before surgery have higher pulmonary complications but similar short-term mortality rates to those who quit. The findings may influence surgical decision-making for patients unable to stop smoking. — Photo by Aakash Dhage on Unsplash (Unsplash License)
SHARE
1 min read|136 words

The University of Cincinnati’s research on lung cancer surgery outcomes provides three critical findings for clinical practice. First, short-term mortality rates remain similar between patients who continue smoking and those who quit before surgical resection, suggesting smoking status alone should not determine surgical candidacy. Second, current smokers experience demonstrably higher pulmonary complications, including pneumonia and respiratory failure, requiring enhanced perioperative surveillance and intervention protocols. Third, these findings suggest that smoking cessation, while clinically desirable, may not be a mandatory prerequisite for surgical consideration in lung cancer patients—a paradigm shift that could expand access to potentially life-saving procedures. Clinicians should use these insights to individualize surgical decision-making, weighing complication risks against the benefits of timely surgical intervention. The data support a more nuanced approach to preoperative smoking status assessment. Read the full article on GMJ Newsroom.

Was this article helpful?

GMJ Brief · Takeaway

📰 Read the full article: Continued smoking before lung cancer surgery increases pulmonary complications but not short-term mortality →

Related reference
  • Lung Cancer · Condition
  • Pneumonia · Condition
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
AI Agent Matches Hematology Experts in Cancer Treatment Decisions, Nature Medicine Study Shows

A case-grounded AI agent has demonstrated high concordance with hematology tumor board…

WHO launches action plan to combat rising fungal disease burden and antifungal resistance

The World Health Organization has released strategic guidance to help countries address…

MHRA Safety Roundup: June 2026 — Key Drug and Device Alerts for Clinicians

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published its…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Vitamin B12 supplement pills with warning symbol representing cancer risk research findings

Long-Term High-Dose B12 Supplements Linked to Significantly Elevated Lung Cancer Risk

By
Prof. Giorgi Pkhakadze
06/07/2026
Clinical UpdatesGlobal HealthPolicy & SystemsPractice

Fifty years after Philadelphia’s deadly outbreak, Legionnaires’ disease remains a persistent public health challenge

By
Prof. Giorgi Pkhakadze
21/06/2026
NHS hospital building representing mental health trust under investigation

Investigation Confirms Multiple Preventable Deaths at Northeast England Mental Health Trust

By
Prof. Giorgi Pkhakadze
22/07/2026
Medical chart showing lung cancer stage distribution trends in Taiwan screening study

What Taiwan’s Lung Cancer Screening Success Means for Global Healthcare Systems

By
Prof. Giorgi Pkhakadze
07/08/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up